Cullinan Associates’s Ecolab ECL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.07M Buy
28,979
+6,653
+30% +$1.75M 0.61% 42
2026
Q1
$5.94M Sell
22,326
-2,874
-11% -$811K 0.48% 53
2025
Q4
$6.62M Buy
25,200
+1,394
+6% +$371K 0.45% 56
2025
Q3
$6.52M Buy
23,806
+340
+1% +$92.4K 0.42% 54
2025
Q2
$6.32M Buy
23,466
+2,455
+12% +$624K 0.42% 53
2025
Q1
$5.33M Sell
21,011
-2,903
-12% -$732K 0.38% 57
2024
Q4
$5.6M Buy
23,914
+6,791
+40% +$1.69M 0.36% 59
2024
Q3
$4.44M Buy
17,123
+9,374
+121% +$2.29M 0.25% 82
2024
Q2
$1.84M Buy
7,749
+2,075
+37% +$479K 0.1% 116
2024
Q1
$1.31M Buy
+5,674
New +$1.2M 0.07% 137
2023
Q1
Sell
-1,790
Closed -$261K 253
2022
Q4
$261K Buy
+1,790
New +$263K 0.01% 254

Other funds holding ECL

Cullinan Associates's ECL Position: Q2 2026 in Review

Cullinan Associates increased its Ecolab (ECL) stake by 30% in Q2 2026, buying an estimated $1.75M and bringing the position to 28,979 shares worth $8.07M. The position accounts for 0.61% of the portfolio, ranked #42.

Cullinan Associates first reported a position in ECL in Q4 2022 and has held it in 11 quarters since. 1,710 funds tracked by Wall St. Rank hold ECL as of Q2 2026.

  • Cullinan Associates held 28,979 shares of Ecolab worth $8.07M as of Q2 2026.
  • Cullinan Associates bought 6,653 Ecolab shares in Q2 2026, an estimated $1.75M.
  • Ecolab made up 0.61% of Cullinan Associates's portfolio in Q2 2026, its #42 holding.
  • Cullinan Associates first reported a position in Ecolab in Q4 2022 and has held it in 11 quarters since.
  • 1,710 funds tracked by Wall St. Rank held Ecolab as of Q2 2026.

Based on Cullinan Associates's 13F filing for Q2 2026, filed 29 Jul 2026.